Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.

Vink FJ, Meijer CJLM, Clifford GM, Poljak M, Oštrbenk A, Petry KU, Rothe B, Bonde J, Pedersen H, de Sanjosé S, Torres M, Del Pino M, Quint WGV, Cuschieri K, Alcañiz Boada E, van Trommel NE, Lissenberg-Witte BI, Floore AN, Hesselink AT, Steenbergen RDM, Bleeker MCG, Heideman DAM.

Int J Cancer. 2019 Aug 7. doi: 10.1002/ijc.32614. [Epub ahead of print]

PMID:
31390052
2.

Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus.

Enkirch T, Severi E, Vennema H, Thornton L, Dean J, Borg ML, Ciccaglione AR, Bruni R, Christova I, Ngui SL, Balogun K, Němeček V, Kontio M, Takács M, Hettmann A, Korotinska R, Löve A, Avellón A, Muñoz-Chimeno M, de Sousa R, Janta D, Epštein J, Klamer S, Suin V, Aberle SW, Holzmann H, Mellou K, Ederth JL, Sundqvist L, Roque-Afonso AM, Filipović SK, Poljak M, Vold L, Stene-Johansen K, Midgley S, Fischer TK, Faber M, Wenzel JJ, Takkinen J, Leitmeyer K.

Euro Surveill. 2019 Jul;24(28). doi: 10.2807/1560-7917.ES.2019.24.28.1800397.

3.

Municipally sponsored human papillomavirus (HPV) vaccination of boys in Slovenia: the first 4 years.

Troha M, Šterbenc A, Mlaker M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2019 Jun;28(2):71-74.

4.

A novel reassortant mammalian orthoreovirus with a divergent S1 genome segment identified in a traveler with diarrhea.

Mikuletič T, Steyer A, Kotar T, Zorec TM, Poljak M.

Infect Genet Evol. 2019 Sep;73:378-383. doi: 10.1016/j.meegid.2019.06.002. Epub 2019 Jun 5.

PMID:
31176029
5.

Piloting a surveillance system for HIV drug resistance in the European Union.

van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK.

Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1800390.

6.

Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies.

Xu L, Benoy I, Cuschieri K, Poljak M, Bonde J, Arbyn M.

Expert Rev Mol Diagn. 2019 Jun;19(6):543-551. doi: 10.1080/14737159.2019.1613890. Epub 2019 May 8.

PMID:
31035813
7.

Novel Circo-Like Virus Detected in a Croatian Bat Population.

Šimić I, Zorec TM, Krešić N, Poljak M, Bedeković T, Lojkić I.

Microbiol Resour Announc. 2019 Apr 18;8(16). pii: e00280-19. doi: 10.1128/MRA.00280-19.

8.

Current mentorship practices in the training of the next generation of clinical microbiology and infectious disease specialists: an international cross-sectional survey.

Ong DSY, Zapf TC, Cevik M, Palacios-Baena ZR, Barać A, Cimen C, Maraolo AE, Rönnberg C, Cambau E, Poljak M; Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):659-665. doi: 10.1007/s10096-019-03509-y. Epub 2019 Feb 19.

9.

Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.

Floore A, Hesselink A, Oštrbenk A, Alcaniz E, Rothe B, Pedersen H, Torres Hortal M, Doorn S, Quint W, Petry KU, Poljak M, Cuschieri K, Bonde J, de Sanjosé S, Bleeker M, Heideman D.

J Clin Lab Anal. 2019 May;33(4):e22854. doi: 10.1002/jcla.22854. Epub 2019 Feb 13.

PMID:
30758084
10.

Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends.

Lunar MM, Židovec Lepej S, Poljak M.

Infect Genet Evol. 2019 Apr;69:146-152. doi: 10.1016/j.meegid.2019.01.015. Epub 2019 Jan 22.

PMID:
30682549
11.

Recent advances in prophylactic human papillomavirus (HPV) vaccination: a review of key literature published between September 2017 and September 2018.

Šterbenc A, Maver PJ, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2018 Dec;27(4):193-201. Review.

12.

Clinical, Histopathological, and Virological Evaluation of 203 Patients With a Clinical Diagnosis of Molluscum Contagiosum.

Trčko K, Hošnjak L, Kušar B, Zorec TM, Kocjan BJ, Križmarić M, Seme K, Miljković J, Luzar B, Poljak M.

Open Forum Infect Dis. 2018 Nov 12;5(11):ofy298. doi: 10.1093/ofid/ofy298. eCollection 2018 Nov.

13.

Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.

Fröberg M, Östensson E, Belkić K, Oštrbenk A, Poljak M, Mints M, Arbyn M, Andersson S.

Cancer. 2019 Jan 15;125(2):239-248. doi: 10.1002/cncr.31788. Epub 2018 Dec 10.

PMID:
30536370
14.

A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study.

Jakupi X, Mlakar J, Lunar MM, Seme K, Rudhani I, Raka L, Vince A, Poljak M.

BMC Nephrol. 2018 Nov 3;19(1):304. doi: 10.1186/s12882-018-1100-5.

15.

New Insights into the Evolutionary and Genomic Landscape of Molluscum Contagiosum Virus (MCV) based on Nine MCV1 and Six MCV2 Complete Genome Sequences.

Zorec TM, Kutnjak D, Hošnjak L, Kušar B, Trčko K, Kocjan BJ, Li Y, Križmarić M, Miljković J, Ravnikar M, Poljak M.

Viruses. 2018 Oct 26;10(11). pii: E586. doi: 10.3390/v10110586.

16.

Pre-vaccination prevalence of high-risk human papillomaviruses (HPV) in women from Kosovo and their related sociodemographic characteristics.

Zejnullahu Raçi P, Hošnjak L, Poljak M, Lepej SŽ, Vince A.

Ginekol Pol. 2018;89(9):485-494. doi: 10.5603/GP.a2018.0083.

17.

High prevalence of Gammapapillomaviruses (Gamma-PVs) in pre-malignant cutaneous lesions of immunocompetent individuals using a new broad-spectrum primer system, and identification of HPV210, a novel Gamma-PV type.

Bolatti EM, Hošnjak L, Chouhy D, Re-Louhau MF, Casal PE, Bottai H, Kocjan BJ, Stella EJ, Gorosito MD, Sanchez A, Bussy RF, Poljak M, Giri AA.

Virology. 2018 Dec;525:182-191. doi: 10.1016/j.virol.2018.09.006. Epub 2018 Oct 4.

PMID:
30292127
18.

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.

van Leeuwen RW, Oštrbenk A, Poljak M, van der Zee AGJ, Schuuring E, Wisman GBA.

Int J Cancer. 2019 Feb 15;144(4):746-754. doi: 10.1002/ijc.31897. Epub 2018 Oct 31.

19.

Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review.

Kmet Lunaček N, Poljak M, Matičič M.

Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):141-146. Review.

20.
21.

Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort.

Artemchuk H, Eriksson T, Poljak M, Surcel HM, Dillner J, Lehtinen M, Faust H.

J Infect Dis. 2019 Jan 29;219(4):582-589. doi: 10.1093/infdis/jiy545.

PMID:
30239832
22.

Validation of EUROArray HPV test using the VALGENT framework.

Viti J, Poljak M, Oštrbenk A, Bhatia R, Alcañiz Boada E, Cornall AM, Cuschieri K, Garland S, Xu L, Arbyn M.

J Clin Virol. 2018 Nov;108:38-42. doi: 10.1016/j.jcv.2018.09.005. Epub 2018 Sep 10.

PMID:
30223253
23.

Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.

Ivanus U, Jerman T, Fokter AR, Takac I, Prevodnik VK, Marcec M, Gajsek US, Pakiz M, Koren J, Celik SH, Kramberger KG, Klopcic U, Kavalar R, Zatler SS, Kuzmanov BG, Florjancic M, Nolde N, Novakovic S, Poljak M, Zakelj MP.

Radiol Oncol. 2018 Sep 14;52(4):399-412. doi: 10.2478/raon-2018-0036.

24.

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

Oštrbenk A, Xu L, Arbyn M, Poljak M.

J Clin Microbiol. 2018 Oct 25;56(11). pii: e01176-18. doi: 10.1128/JCM.01176-18. Print 2018 Nov.

25.

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework.

Xu L, Padalko E, Oštrbenk A, Poljak M, Arbyn M.

Int J Mol Sci. 2018 Sep 11;19(9). pii: E2704. doi: 10.3390/ijms19092704.

26.

Seropositivity to Multiple Anogenital Human Papillomavirus (HPV) Types Is Associated With Current Anogenital HPV Infection, Abnormal Cytology, and Seropositivity for Nongenital HPVs.

Faust H, Artemchuk H, Oštrbenk A, Triglav T, Poljak M, Dillner J.

J Infect Dis. 2019 Jan 9;219(3):489-496. doi: 10.1093/infdis/jiy523.

PMID:
30202984
27.

Prevalence of the Helicobacter pylori homA and homB genes and their correlation with histological parameters in children.

Šterbenc A, Poljak M, Zidar N, Luzar B, Homan M.

Microb Pathog. 2018 Dec;125:26-32. doi: 10.1016/j.micpath.2018.09.005. Epub 2018 Sep 6.

28.

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.

Arbyn M, Peeters E, Benoy I, Vanden Broeck D, Bogers J, De Sutter P, Donders G, Tjalma W, Weyers S, Cuschieri K, Poljak M, Bonde J, Cocuzza C, Zhao FH, Van Keer S, Vorsters A.

J Clin Virol. 2018 Oct;107:52-56. doi: 10.1016/j.jcv.2018.08.006. Epub 2018 Aug 22.

PMID:
30195193
29.

ESCMID white paper: a guide on ESCMID guidance documents.

Scudeller L, Rodríguez-Baño J, Zinkernagel A, Tacconelli E, Akova M, Friedrich AW, Sanguinetti M, Paul M, Poljak M.

Clin Microbiol Infect. 2019 Feb;25(2):155-162. doi: 10.1016/j.cmi.2018.08.005. Epub 2018 Aug 24.

PMID:
30145398
30.

Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017.

Ndumbi P, Freidl GS, Williams CJ, Mårdh O, Varela C, Avellón A, Friesema I, Vennema H, Beebeejaun K, Ngui SL, Edelstein M, Smith-Palmer A, Murphy N, Dean J, Faber M, Wenzel J, Kontio M, Müller L, Midgley SE, Sundqvist L, Ederth JL, Roque-Afonso AM, Couturier E, Klamer S, Rebolledo J, Suin V, Aberle SW, Schmid D, De Sousa R, Augusto GF, Alfonsi V, Del Manso M, Ciccaglione AR, Mellou K, Hadjichristodoulou C, Donachie A, Borg ML, Sočan M, Poljak M, Severi E; Members Of The European Hepatitis A Outbreak Investigation Team.

Euro Surveill. 2018 Aug;23(33). doi: 10.2807/1560-7917.ES.2018.23.33.1700641.

31.

Progress in vaccines and vaccination - Best of ECCMID 2016.

Poljak M.

Vaccine. 2018 Aug 28;36(36):5349. doi: 10.1016/j.vaccine.2018.07.050. Epub 2018 Jul 25. No abstract available.

PMID:
30055968
32.

Human papillomavirus (HPV) infection and vaccination: knowledge and attitudes among healthcare professionals and the general public in Slovenia.

Troha M, Šterbenc A, Mlaker M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2018 Jun;27(2):59-64.

33.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

34.

Prevalence and correlates of beta human papillomavirus detection in fingernail samples from mid-adult women.

Winer RL, Gheit T, Cherne S, Lin J, Stern JE, Poljak M, Feng Q, Tommasino M.

Papillomavirus Res. 2018 Jun;5:1-5. doi: 10.1016/j.pvr.2017.11.002. Epub 2017 Nov 10.

35.

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.

Lunar MM, Židovec Lepej S, Tomažič J, Vovko TD, Pečavar B, Turel G, Maver M, Poljak M.

PLoS One. 2018 Apr 26;13(4):e0196670. doi: 10.1371/journal.pone.0196670. eCollection 2018.

36.

Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study.

Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, Filipic M, Flezar MS, Kirbis IS, Rotter A, Brozic A, Zakelj MN, Poljak M, Hosnjak L, Groselj B, Strojan P, Sersa G.

Radiat Res. 2018 Jun;189(6):644-651. doi: 10.1667/RR14984.1. Epub 2018 Apr 13.

PMID:
29652621
37.

HIV care in Central and Eastern Europe: How close are we to the target?

Gokengin D, Oprea C, Begovac J, Horban A, Zeka AN, Sedlacek D, Allabergan B, Almamedova EA, Balayan T, Banhegyi D, Bukovinova P, Chkhartishvili N, Damira A, Deva E, Elenkov I, Gashi L, Gexha-Bunjaku D, Hadciosmanovic V, Harxhi A, Holban T, Jevtovic D, Jilich D, Kowalska J, Kuvatova D, Ladnaia N, Mamatkulov A, Marjanovic A, Nikolova M, Poljak M, Rüütel K, Shunnar A, Stevanovic M, Trumova Z, Yurin O.

Int J Infect Dis. 2018 May;70:121-130. doi: 10.1016/j.ijid.2018.03.007. Epub 2018 Mar 14.

38.

Seroprevalences of Antibodies to 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure.

Artemchuk H, Triglav T, Oštrbenk A, Poljak M, Dillner J, Faust H.

J Infect Dis. 2018 Jul 2;218(3):398-405. doi: 10.1093/infdis/jiy107.

PMID:
29529245
39.

Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.

De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M.

Intensive Care Med. 2018 Feb;44(2):189-196. doi: 10.1007/s00134-017-5036-1. Epub 2017 Dec 29.

PMID:
29288367
40.

Detection of novel Betapapillomaviruses and Gammapapillomaviruses in eyebrow hair follicles using a single-tube 'hanging droplet' PCR assay with modified pan-PV CODEHOP primers.

Chouhy D, Kocjan BJ, Staheli JP, Bolatti EM, Hošnjak L, Sagadin M, Giri AA, Rose TM, Poljak M.

J Gen Virol. 2018 Jan;99(1):109-118. doi: 10.1099/jgv.0.000988. Epub 2017 Dec 15.

41.

Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.

Xu L, Oštrbenk A, Poljak M, Arbyn M.

J Clin Virol. 2018 Jan;98:37-42. doi: 10.1016/j.jcv.2017.12.001. Epub 2017 Dec 6.

PMID:
29241150
42.

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.

Cornall AM, Poljak M, Garland SM, Phillips S, Machalek DA, Tan JH, Quinn MA, Tabrizi SN.

Papillomavirus Res. 2017 Dec;4:79-84. doi: 10.1016/j.pvr.2017.10.002. Epub 2017 Oct 18.

43.

Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).

Poljak M, Šterbenc A, Lunar MM.

Expert Rev Anti Infect Ther. 2017 Nov;15(11):987-999. doi: 10.1080/14787210.2017.1392854. Epub 2017 Oct 20. Review.

PMID:
29027811
44.

Molecular characterization, prevalence and clinical relevance of Phodopus sungorus papillomavirus type 1 (PsuPV1) naturally infecting Siberian hamsters (Phodopus sungorus).

Kocjan BJ, Hošnjak L, Račnik J, Zadravec M, Bakovnik N, Cigler B, Ummelen M, Hopman AHN, Gale N, Švara T, Gombač M, Poljak M.

J Gen Virol. 2017 Nov;98(11):2799-2809. doi: 10.1099/jgv.0.000943. Epub 2017 Oct 12.

PMID:
29022861
45.

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.

Polman NJ, Oštrbenk A, Xu L, Snijders PJF, Meijer CJLM, Poljak M, Heideman DAM, Arbyn M.

J Clin Microbiol. 2017 Dec;55(12):3544-3551. doi: 10.1128/JCM.01282-17. Epub 2017 Oct 11.

46.

A32 Search for viral integration insertion sites into the human genome-strategy matters.

Zorec TM, Hošnjak L, Kocjan B, Gale N, Zidar N, Strojan P, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.031. doi: 10.1093/ve/vew036.031. eCollection 2017 Mar. No abstract available.

47.

A36 Prevalence of HIV-1 subtypes in Slovenia with an emphasis on molecular and phylogenetic investigation of subtype A.

Mlakar J, Lunar MM, Abecasis AB, Vandamme AM, Tomažič J, Vovko TD, Pečavar B, Volčanšek G, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.035. doi: 10.1093/ve/vew036.035. eCollection 2017 Mar. No abstract available.

48.

A22 Increase in the numbers of HIV-1 non-B subtypes and potential recombinant forms circulating among Slovenian MSM in recent years.

Lunar MM, Mlakar J, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.021. doi: 10.1093/ve/vew036.021. eCollection 2017 Mar. No abstract available.

49.

Corrigendum: Natural history of human papillomavirus infection of sun-exposed healthy skin of immunocompetent individuals over three climatic seasons and identification of HPV209, a novel betapapillomavirus.

Bolatti EM, Chouhy D, Hošnjak L, Casal PE, Kocjan BJ, Bottai H, Stella EJ, Sanchez A, Fernandez Bussy R, Poljak M, Giri AA.

J Gen Virol. 2017 Aug;98(8):2205-2206. doi: 10.1099/jgv.0.000900. No abstract available.

PMID:
28825399
50.

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.

Maver PJ, Poljak M.

Vaccine. 2018 Aug 28;36(36):5416-5423. doi: 10.1016/j.vaccine.2017.07.113. Epub 2017 Aug 8. Review.

PMID:
28801154

Supplemental Content

Loading ...
Support Center